With your support, Open Medicine Foundation funds open, collaborative research so that, as soon as possible, precise diagnostic tools and life-changing treatments can be available to people with ME/CFS and related chronic, complex diseases such as Post-Treatment Lyme Disease Syndrome, Fibromyalgia, and Post-COVID Syndrome.
Each OMF funded study is selected, with oversight from our prestigious Scientific Advisory Board, for its ability to provide meaningful data that will fuel the search for treatment and diagnosis. This data is essential to develop diagnostic technologies, understand the molecular basis of the diseases, and uncover effective diagnostic tools and treatments. Because of the contributions from thousands of individuals just like you, over 20 studies have been completed or are underway across five ME/CFS Collaborative Research Centers.
Wenzhong Xiao, PhD, is co-director of The Harvard ME/CFS Collaboration and a world expert in computational genomics. We are thrilled to share this update from Dr. Xiao on his efforts to analyze and integrate the data from OMF funded studies, an essential step in developing diagnostics and treatments.
Wenzhong Xiao, PhD
From the desk of Wenzhong Xiao, PhD
The number of studies of ME/CFS is proliferating. There is an urgent need to conduct computational analysis of the resulting data to uncover the molecular mechanism and identify therapeutic targets of ME/CFS.
Focusing on data from the five OMF funded ME/CFS Collaborative Research Centers, my team strives to understand the molecular mechanism of ME/CFS from the genomic, proteomic, metabolic, and immunologic perspectives.
Sample projects include:
Data Sharing in the OMF ME/CFS Data Center.
Multi-omics of invasive cardiopulmonary exercise test (ICPET) of ME/CFS in collaboration with the Harvard Center.
Systems biology on the disease mechanisms of ME/CFS
Computational analysis plays an essential role in OMF’s research strategy and The End ME/CFS Project conducted within the ME/CFS Collaborative Research Network. I am honored to be part of an outcomes-focused, transparent, and multi-pronged approach to finding answers for people living with ME/CFS and other chronic, complex diseases.
Please support our cutting-edge, privately funded research strategy and effort to sustain the invaluable work of Dr. Xiao, Dr. Davis, Dr. Tompkins, Dr. Bergquist, Dr. Moreau, Dr. Armstrong, and their talented teams.
With your help, we will keep up the momentum and win this fight!
Donate your appreciated stock directly to OMFCA and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).
OMFCA sells your securities and uses the proceeds to support our mission. You also do not pay capital gains tax on the transfer when the stock is sold. Giving appreciated stock can be more beneficial than giving cash. The “cost” of your gift is often less than the deduction you gain by making it. In advance, thank you for making this generous gift.
Gifting of Stock Instructions
Brokerage/Investment Firm: TD Waterhouse
Name on the Account: Open Medicine Foundation Canada
Account Number: 20LRHLA
OMFCA Canadian Revenue Agency (CRA) charity registration #: 74926 5518 RR0001
OMF Canada Registered Address:
Open Medicine Foundation Canada
2987 Baynes Road, Victoria, BC V8N-1Y4
Phone Number: 416-848-0055
Please speak to your personal tax advisor and then call OMFCA at 650-242-8669 to notify us of your donation or with any questions.